Nebracetam
Chemical compound / From Wikipedia, the free encyclopedia
Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats.[1] Based on a human leukemic T cell experiment in 1991, it is believed to act as an agonist for human M1-muscarinic receptors.[2] It is also believed to act as a nootropic, like many other racetam drugs.[3] A chemoenzymatic method of synthesis was reported in 2008.[4] As of 2023[update], human trials have not yet been conducted.
Quick Facts Clinical data, ATC code ...
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C12H16N2O |
Molar mass | 204.273 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
NY (what is this?) (verify) |
Close